Gene Transfer of Inducible Nitric Oxide Synthase Affords Cardioprotection by Upregulating Heme Oxygenase-1 Via a Nuclear Factor-κB-Dependent Pathway
- 29 September 2009
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 120 (13) , 1222-1230
Abstract
Background— Although inducible nitric oxide synthase (iNOS) is known to impart powerful protection against myocardial infarction, the mechanism for this salubrious action remains unclear. Methods and Results— Adenovirus-mediated iNOS gene transfer in mice resulted 48 to 72 hours later in increased expression not only of iNOS protein but also of heme oxygenase (HO)-1 mRNA and protein; HO-2 protein expression did not change. iNOS gene transfer markedly reduced infarct size in wild-type mice, but this effect was completely abrogated in HO-1 −/− mice. At 48 hours after iNOS gene transfer, nuclear factor-κB was markedly activated. In transgenic mice with cardiomyocyte-restricted expression of a dominant negative mutant of IκBα (IκBα S32A,S36A ), both basal HO-1 levels and upregulation of HO-1 by iNOS gene transfer were suppressed. Chromatin immunoprecipitation analysis of mouse hearts provided direct evidence that nuclear factor-κB subunits p50 and p65 were recruited to the HO-1 gene promoter (−468 to −459 bp) 48 hours after iNOS gene transfer. Conclusions— This study demonstrates for the first time the existence of a close functional coupling between cardiac iNOS and cardiac HO-1: iNOS upregulates HO-1 by augmenting nuclear factor-κB binding to the region of the HO-1 gene promoter from −468 to −459 bp, and HO-1 then mediates the cardioprotective effects of iNOS. These results also reveal an important role of nuclear factor-κB in both basal and iNOS-induced expression of cardiac HO-1. Collectively, the present findings significantly expand our understanding of the regulation of cardiac HO-1 and of the mechanism whereby iNOS exerts its cardioprotective actions.Keywords
This publication has 43 references indexed in Scilit:
- Identification of Transcription Factor–DNA Interactions Using Chromatin Immunoprecipitation Assays2009
- Selective Regulation of Heme Oxygenase-1 Expression and Function by Insulin through IRS1/Phosphoinositide 3-Kinase/Akt-2 PathwayJournal of Biological Chemistry, 2008
- Heme Oxygenase-1 Regulates Cardiac Mitochondrial Biogenesis via Nrf2-Mediated Transcriptional Control of Nuclear Respiratory Factor-1Circulation Research, 2008
- Shared Principles in NF-κB SignalingCell, 2008
- Cardioprotection Afforded by Inducible Nitric Oxide Synthase Gene Therapy Is Mediated by Cyclooxygenase-2 via a Nuclear Factor-κB–Dependent PathwayCirculation, 2007
- The late phase of preconditioning and its natural clinical application—gene therapyHeart Failure Reviews, 2007
- Carbon Monoxide and BilirubinAmerican Journal of Respiratory Cell and Molecular Biology, 2007
- Preconditioning: a paradigm shift in the biology of myocardial ischemiaAmerican Journal of Physiology-Heart and Circulatory Physiology, 2007
- 30 some years of heme oxygenase: From a “molecular wrecking ball” to a “mesmerizing” trigger of cellular eventsBiochemical and Biophysical Research Communications, 2005
- A cis -Acting Region Regulates Oxidized Lipid-Mediated Induction of the Human Heme Oxygenase-1 Gene in Endothelial CellsArteriosclerosis, Thrombosis, and Vascular Biology, 2003